SHANGHAI RENDU BIOTECHNOLOGY financial statements, including revenue, expenses, profit, and loss

The total revenue of 688193 for the last quarter is 44.57 M CNY, and it's 5.27% lower compared to the previous quarter. The net income of Q1 24 is 3.70 M CNY.